Endodermal sinus tumor of the ovary: The M. D. Anderson experience

Obstetrics and Gynecology

Volumn 61, Issue 2, 1983, Pages 194-202

  Gershenson, David M ^a   Junco, Gerard Del ^a   Herson, Jay ^a   Rutledge, Felix N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL STUDY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; HUMAN; OVARY CANCER; THERAPY;

ADOLESCENT; ADULT; BLEOMYCIN; CASTRATION; CHILD; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HUMAN; MESONEPHROMA; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; VINBLASTINE; VINCRISTINE;

EID: 0020659057     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Schiller W: Mesonephroma ovarii. Am J Cancer 35:1, 1939
2. Teilum G: Gonocytoma: Homologous ovarian and testicular tumors. I. With discussion of "Mesonephroma ovarii" (Schiller: Am J Cancer, 1939). Acta Pathol Microbiol Scand 23:242, 1946
3. Teilum G: Endodermal sinus tumors of the ovary and testis, comparative morphogenesis of the so-called mesonephroma ovarii (Schiller) and extraembryonic (yolk-sac-allantoic) structures of the rat's placenta. Cancer 12:1092, 1959
4. Teilum G: Classification of endodermal sinus tumors (mesoblastoma vitellinum) and so-called "embryonal carcinomas" of the ovary. Acta Pathol Microbiol Scand 64:407, 1965
5. Teilum G: The concept of endodermal sinus (yolk sac) tumor. Scand J Immunol 8:75 (Suppl), 1978
6. Kurman RJ, Norris HJ: Endodermal sinus tumor of the ovary. A clinical and pathologic analysis of 71 cases. Cancer 38:2404, 1976
7. Ballas M: Yolk sac carcinoma of ovary with alpha fetoprotein in the serum and ascitic fluid demonstrated by immunoosmophoresis. Am J Clin Pathol 57:511, 1972
8. Norgaard-Pedersen B. Albrechtesen R, Teilum G: Serum alphafetoprotein as a marker for endodermal sinus tumor (yolk sac tumor) or a vitelline component of teratocarcinoma. Acta Pathol Microbiol Scand (A) 83:573, 1975
9. Itoh T, Shirai T, Naka A, et al: Yolk sac tumor and α-fetoprotein. Clinico-pathological study of four cases. Gan 65:215, 1974
10. Talerman A, Haije WG: Alpha-fetoprotein and germ cell tumors: A possible role of yolk sac tumor in production of alphafetoprotein. Cancer 34:1722, 1974
11. Tsuchida Y, Saito S, Ishida M, et al: Yolk sac tumor and alphafetoprotein. A report of three cases. Cancer 32:917, 1973
12. Wilkinson EJ, Friedrich EG, Hosty TA: Alpha-fetoprotein and endodermal sinus tumor of ovary. Am J Obstet Gynecol 116:711, 1973
13. Kurman RJ, Norris HJ: Embryonal carcinoma of the ovary. Cancer 38:2420, 1976
14. Serov SF, Scully RE, Sobin LH: Histological typing of ovarian tumors. International Histological Classification of Tumors, No. 9, Geneva, World Health Organization, 1973
15. Jimerson GK, Woodruff JD: Ovarian extraembryonal teratoma. Am J Obstet Gynecol 127:73, 1977
16. Smith JP, Rutledge FN: Advances in chemotherapy for gynecologic cancer. Cancer 36:669, 1975
17. Samuels ML, Holoye PY, Johnson DE: Bleomycin combination chemotherapy in the management of testicular neoplasia. Cancer 36:318, 1975
18. Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293, 1977
19. Julian CG, Barrett JM, Richardson RL, et al: Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumor. Obstet Gynecol 56:396, 1979
20. Lokey JL, Baker JJ, Price NA, et al: Cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovary. Ann Intern Med 94:56, 1981
21. Williams S, Slayton R, Silverberg S, et al: Response of malignant ovarian germ cell tumors to cis-platinum, vinblastine, and bleomycin (PVB). Proc Am Assoc Cancer Res and Am Soc Clin Oncol 22:463, 1981 (C-509)
22. Berkson J, Gage RP: Survival curve for cancer patients following treatment. J Am Stat Assoc 47:501, 1952
23. Gitlin D, Perricelli A, Gitlin GM: Synthesis of alpha-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res 32:979, 1972
24. Forney JP, DiSaia PJ, Morrow PC: Endodermal sinus tumor-a report of two sustained remissions treated postoperatively with a combination of actinomycin-D, 5-fluorouracil and cyclophosphamide. Obstet Gynecol 45:186, 1975
25. Cangir A, Smith J, VanEys J: Improved prognosis in children with ovarian cancers following modified VAC chemotherapy. Cancer 42:1234, 1978
26. Slayton RE, Hreshchyshyn MM, Silberberg SG, et al: Treatment of malignant ovarian germ cell tumors-response to vincristine, dactinomycin, and cyclophosphamide. Cancer 42:390, 1978
27. Jacobs AJ, Harris M, Deppe G, et al: Treatment of recurrent germ cell tumors with cisplatin, vinblastine, and bleomycin. Obstet Gynecol 59:129, 1982
28. Romero R, Schwartz P: Alpha fetoprotein determinations in the management of endodermal sinus tumors and mixed germ cell tumors of the ovary. Am J Obstet Gynecol 141:126, 1981
29. Sell A, Sogaard H, Norgaard-Pedersen B: Serum alpha-fetoprotein as a marker for the effect of chemotherapy in eight cases of ovarian endodermal sinus tumor. Int J Cancer 18:574, 1976
30. Horning SJ, Hoppe RT, Kaplan HS, et al: Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 304:1377, 1981
31. Warne GL, Fairley KF, Hobbs JB, Martin FIR: Cyclophosphamide-induced ovarian failure. N Engl J Med 289:1159, 1973
32. Siris ES, Leventhal BG, Vaitukaitis JL: Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med 294:1143, 1976
33. Blatt J, Poplack DG, Sherins RJ: Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med 304:1121, 1981
34. Stillman RJ, Schinfeld JS, Schiff I, et al: Ovarian failure in longterm survivors of childhood malignancy. Am J Obstet Gynecol 139:62, 1981